FIELD: medicine.
SUBSTANCE: peroral medicinal form with immediate release of derivatives of benzapene-1-acetic acid includes said active substance in amount up to 65% of total weight of medicinal form; 10% wt of alkaline compound or mixture of alkaline compounds; from 0.1 to 10% of one or more surface-active substances, and optionally includes auxiliary materials in amount from 1% to 45% of total medicinal form weight. Invention also relates to methods of obtaining said medicinal form.
EFFECT: invention allows to obtain stable in application medicinal forms with increased biological availability of active substance.
21 cl, 3 dwg, 5 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ORAL COMPOSITION COMPRISING DIFFICULTLY WATER-SOLUBLE ACTIVE SUBSTANCE SOLID SOLUTION | 2003 |
|
RU2314811C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING S1P RECEPTOR MODULATOR | 2007 |
|
RU2487703C2 |
| CONTROLLED RELEASE SOLID DRUG | 2006 |
|
RU2467740C2 |
| SOLID BENZAZEPIN COMPOUND SALTS AND THEIR USE IN PREPARATION OF PHARMACEUTICAL COMPOUNDS | 2003 |
|
RU2303041C2 |
| DIRECTLY PRESSED MATRIX FOR REGULATED RELEASE OF SINGLE DAILY CLARITHROMYCIN DOSES | 2000 |
|
RU2237480C2 |
| PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2589842C2 |
| CONTROLLED RELEASE SOLID PREPARATION | 2006 |
|
RU2496480C2 |
| ALKYLTHIOPYRIMIDINES AS CRTH2 ANTAGONISTS | 2008 |
|
RU2491280C2 |
| COMPOSITIONS AND METHODS OF TREATMENT OF IRRITABLE BOWEL SYNDROME | 2017 |
|
RU2751770C2 |
| COMPOSITIONS AND METHODS FOR TREATING CANCER | 2017 |
|
RU2770081C2 |
